DexCom Inc (DXCM)
126.75
-1.44
(-1.12%)
USD |
NASDAQ |
May 10, 13:39
DexCom Profit Margin (Quarterly): 15.90% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 15.90% |
December 31, 2023 | 24.78% |
September 30, 2023 | 12.38% |
June 30, 2023 | 13.30% |
March 31, 2023 | 6.55% |
December 31, 2022 | 11.26% |
September 30, 2022 | 13.15% |
June 30, 2022 | 7.31% |
March 31, 2022 | 15.47% |
December 31, 2021 | -0.76% |
September 30, 2021 | 13.43% |
June 30, 2021 | 13.17% |
March 31, 2021 | 11.19% |
December 31, 2020 | 62.44% |
September 30, 2020 | 14.41% |
June 30, 2020 | 10.25% |
March 31, 2020 | 4.91% |
December 31, 2019 | 20.03% |
September 30, 2019 | 11.56% |
June 30, 2019 | -3.12% |
March 31, 2019 | -9.59% |
December 31, 2018 | -53.17% |
September 30, 2018 | 17.47% |
June 30, 2018 | 12.45% |
March 31, 2018 | -13.12% |
Date | Value |
---|---|
December 31, 2017 | -4.25% |
September 30, 2017 | -1.08% |
June 30, 2017 | 1.70% |
March 31, 2017 | -29.30% |
December 31, 2016 | -4.32% |
September 30, 2016 | -12.65% |
June 30, 2016 | -14.71% |
March 31, 2016 | -16.52% |
December 31, 2015 | 1.15% |
September 30, 2015 | -40.40% |
June 30, 2015 | -3.97% |
March 31, 2015 | -17.72% |
December 31, 2014 | 1.54% |
September 30, 2014 | -7.54% |
June 30, 2014 | -10.20% |
March 31, 2014 | -26.54% |
December 31, 2013 | -5.03% |
September 30, 2013 | -13.99% |
June 30, 2013 | -28.21% |
March 31, 2013 | -37.50% |
December 31, 2012 | -25.53% |
September 30, 2012 | -74.89% |
June 30, 2012 | -62.82% |
March 31, 2012 | -70.15% |
December 31, 2011 | -54.35% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-3.12%
Minimum
Jun 2019
62.44%
Maximum
Dec 2020
13.88%
Average
12.76%
Median
Profit Margin (Quarterly) Benchmarks
Abbott Laboratories | 12.29% |
Edwards Lifesciences Corp | 22.02% |
Boston Scientific Corp | 12.76% |
Cardinal Health Inc | 0.47% |
Insulet Corp | 20.26% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | 29.28% |
Return on Assets | 10.09% |
Return on Invested Capital | 13.59% |
Gross Profit Margin (Quarterly) | 61.01% |
Operating Margin (Quarterly) | 10.98% |
Return on Net Operating Assets | 23.15% |